Xiang Gu

2.6k total citations
63 papers, 2.0k citations indexed

About

Xiang Gu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiang Gu has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Xiang Gu's work include RNA modifications and cancer (7 papers), Ocular Oncology and Treatments (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiang Gu is often cited by papers focused on RNA modifications and cancer (7 papers), Ocular Oncology and Treatments (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiang Gu collaborates with scholars based in China, United States and Germany. Xiang Gu's co-authors include Shengfang Ge, Xianqun Fan, Stephan Lang, Sven Brandau, Peiwei Chai, Claudia A. Dumitru, Ágnes Bánkfalvi, Ai Zhuang, Renbing Jia and Jie Yu and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Xiang Gu

58 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiang Gu China 26 875 475 452 410 177 63 2.0k
Manuel Deprez Belgium 27 899 1.0× 365 0.8× 374 0.8× 266 0.6× 246 1.4× 68 2.3k
Daniela F. Angelini Italy 31 1.2k 1.4× 831 1.7× 367 0.8× 542 1.3× 113 0.6× 55 2.8k
Liang Guo China 24 1.0k 1.2× 295 0.6× 528 1.2× 499 1.2× 202 1.1× 98 2.1k
Lili Wei China 24 537 0.6× 247 0.5× 293 0.6× 279 0.7× 108 0.6× 82 1.5k
Mónika Göőz United States 24 754 0.9× 313 0.7× 282 0.6× 165 0.4× 185 1.0× 60 1.8k
Qiao Mei China 27 1.7k 2.0× 151 0.3× 385 0.9× 605 1.5× 131 0.7× 100 2.5k
Jin Ren United States 23 791 0.9× 593 1.2× 477 1.1× 246 0.6× 123 0.7× 45 1.9k
Nicholas J. Roberts United States 21 554 0.6× 273 0.6× 707 1.6× 522 1.3× 149 0.8× 51 1.8k
Wenyong Long China 16 961 1.1× 144 0.3× 172 0.4× 375 0.9× 166 0.9× 38 1.5k
Gualtiero I. Colombo Italy 27 970 1.1× 449 0.9× 205 0.5× 316 0.8× 187 1.1× 105 2.5k

Countries citing papers authored by Xiang Gu

Since Specialization
Citations

This map shows the geographic impact of Xiang Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Gu more than expected).

Fields of papers citing papers by Xiang Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Gu. The network helps show where Xiang Gu may publish in the future.

Co-authorship network of co-authors of Xiang Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Gu. A scholar is included among the top collaborators of Xiang Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Gu. Xiang Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Ziyue, Jie Chen, Tianyu Zhu, et al.. (2025). Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications. Molecular Cancer. 25(1). 19–19.
2.
3.
Zhang, Lingyu, Hui Pan, Yiran Yao, et al.. (2024). Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma. Asia-Pacific Journal of Ophthalmology. 13(5). 100108–100108.
4.
Zhuang, Ai, Xiang Gu, Tongxin Ge, et al.. (2023). Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m 6 A RNA methylation in ocular melanoma. Cancer Communications. 43(11). 1185–1206. 21 indexed citations
5.
Gu, Xiang, Ai Zhuang, Jie Yu, et al.. (2023). Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A. Nucleic Acids Research. 52(5). 2273–2289. 80 indexed citations
6.
Gu, Xiang, Ziyue Huang, Jie Chen, et al.. (2023). Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line. Investigative Ophthalmology & Visual Science. 64(15). 16–16. 1 indexed citations
7.
Yu, Jie, Ai Zhuang, Xiang Gu, et al.. (2023). Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis. Cell Discovery. 9(1). 33–33. 59 indexed citations
8.
Li, Lin, Xuyang Wen, Xiang Gu, et al.. (2023). NSUN2‐mediated m5C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression. Clinical and Translational Medicine. 13(5). e1273–e1273. 45 indexed citations
9.
Ge, Tongxin, Xiang Gu, Renbing Jia, et al.. (2022). Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Communications. 42(11). 1049–1082. 114 indexed citations
10.
Guo, Yixuan, Yuanyuan Liu, Xiang Gu, et al.. (2022). Pyruvate: Ferredoxin oxidoreductase is involved in IgA-related microbiota dysbiosis and intestinal inflammation. Frontiers in Immunology. 13. 1040774–1040774. 4 indexed citations
11.
Gu, Xiang, Jie Yu, Ludi Yang, et al.. (2022). Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma. Journal of Pharmaceutical Analysis. 13(1). 24–38. 8 indexed citations
12.
13.
Chai, Peiwei, Ruobing Jia, Yongyun Li, et al.. (2021). Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Progress in Retinal and Eye Research. 89. 101030–101030. 34 indexed citations
14.
Yang, Ludi, Xiang Gu, Jie Yu, Shengfang Ge, & Xianqun Fan. (2021). Oncolytic Virotherapy: From Bench to Bedside. Frontiers in Cell and Developmental Biology. 9. 790150–790150. 43 indexed citations
15.
Gu, Xiang, et al.. (2018). Tumor-infiltrating CD45RO+ memory cells correlate with favorable prognosis in patients with lung adenocarcinoma. Journal of Thoracic Disease. 10(4). 2089–2099. 41 indexed citations
16.
Zhu, Ye & Xiang Gu. (2016). GW27-e0048 A mitochondrial mutation A8701G is associated with maternally inherited hypertension and dilated cardiomyopathy in a Chinese pedigree of a consanguineous marriage. Journal of the American College of Cardiology. 68(16). C132–C132. 1 indexed citations
17.
Dumitru, Claudia A., Ágnes Bánkfalvi, Xiang Gu, et al.. (2013). AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma. PLoS ONE. 8(2). e56420–e56420. 51 indexed citations
18.
Dumitru, Claudia A., Ágnes Bánkfalvi, Xiang Gu, et al.. (2013). Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma. Frontiers in Immunology. 4. 33–33. 26 indexed citations
19.
Wild, C., Sven Brandau, Ramin Lotfi, et al.. (2012). HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer. Oral Oncology. 48(5). 409–416. 64 indexed citations
20.
Gu, Haijuan, Xiaohong Guo, Ping Feng, et al.. (2010). The functional polymorphism in monocyte chemoattractant protein-1 gene increases susceptibility to gastric cancer. Medical Oncology. 28(S1). 280–285. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Deprez Breakdown of academic impact, for papers by Daniela F. Angelini Breakdown of academic impact, for papers by Liang Guo Breakdown of academic impact, for papers by Lili Wei Breakdown of academic impact, for papers by Mónika Göőz Breakdown of academic impact, for papers by Qiao Mei Breakdown of academic impact, for papers by Jin Ren Breakdown of academic impact, for papers by Nicholas J. Roberts Breakdown of academic impact, for papers by Wenyong Long Breakdown of academic impact, for papers by Gualtiero I. Colombo
Rankless by CCL
2026